Measurement sample preparation method, analysis method, reagent and reagent kit

By preparing a measurement sample through bonding a linker to a test substance and metal nanoparticles, the method enhances the detection sensitivity of analytes, addressing the limitations of existing SERS technologies.

JP7583393B2Active Publication Date: 2024-11-14SYSMEX CORP +2

Patent Information

Application Number
JP2021035593
Authority / Receiving Office
JP · JP
Patent Type
Patents
Current Assignee / Owner
Filing Date
2021-03-05
Publication Date
2024-11-14
Estimated Expiration
2041-03-05

AI Technical Summary

Technical Problem

Existing methods for detecting analytes, such as amino acids in proteins, lack sufficient sensitivity, and there is a need for improved signal enhancement in surface-enhanced Raman scattering (SERS) active particles.

Method used

A method involving the preparation of a measurement sample by bringing a test substance and a linker into contact, bonding them, and then connecting the linker to metal nanoparticles, which are used in conjunction with spectroscopic analysis to enhance detection sensitivity.

Benefits of technology

The method significantly improves the detection sensitivity of analytes by producing a measurement sample that allows for the detection of specific spectral peaks associated with the test substance, enhancing the sensitivity compared to conventional methods.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 0007583393000001
    Figure 0007583393000001
  • Figure 0007583393000002
    Figure 0007583393000002
  • Figure 0007583393000003
    Figure 0007583393000003
Patent Text Reader

Abstract

To improve analyte detection sensitivity.SOLUTION: A method of preparing a measurement sample containing aggregates of metal nanoparticles bound to an analyte is provided to clear the above challenge, the method comprising bringing the analyte into contact with a linker to bind them together, and bringing the linker bound to the analyte into contact with the metal nanoparticles to be bind them together.SELECTED DRAWING: Figure 1
Need to check novelty before this filing date? Find Prior Art

Description

[Technical field]

[0001] The present invention relates to a preparation method, an analysis method, a reagent, and a reagent kit for preparing a measurement sample containing an aggregate of metal nanoparticles bound to a test substance. [Background technology]

[0002] Patent Document 1 discloses positively charged surface-enhanced Raman scattering (SERS)-active particles having a metal-containing particle and a cationic coating on the metal-containing particle. It also discloses SERS-active particles having a metal-containing particle and a nonmetallic molecule, the metal-containing particle being derivatized with the nonmetallic molecule. It also discloses a method of capturing an analyte on the SERS-active particle by contacting the SERS-active particle with the analyte, agglomerating the SERS-active particles capturing the analyte, and detecting a signal of a SERS spectrum. [Prior art documents] [Patent documents]

[0003] [Patent Document 1] U.S. Patent Publication No. 2007 / 0155021 Summary of the Invention [Problem to be solved by the invention]

[0004] Highly sensitive detection of analytes is required in various fields, for example, highly sensitive detection of amino acids in proteins is required in clinical testing. In Patent Document 1, SERS-active particles are used to enhance the signal of the SERS spectrum, thereby improving the detection sensitivity, but further enhancement of the signal is required.

[0005] An object of the present invention is to provide a method for preparing a measurement sample, an analysis method, a reagent for preparing a measurement sample, and a reagent kit, which are intended to improve the detection sensitivity of an analyte. [Means for solving the problem]

[0006] The present invention provides a method for preparing a measurement sample containing an aggregate of metal nanoparticles bound to a test substance, the method comprising: bringing the test substance into contact with a linker to bind the test substance; and bringing the linker bound to the test substance into contact with the metal nanoparticles to bind the test substance. This makes it possible to prepare a measurement sample capable of detecting the test substance with high sensitivity.

[0007] The present invention relates to an analytical method including: acquiring a spectroscopic spectrum from a measurement sample prepared by the preparation method; and outputting information about the test substance based on the acquired spectroscopic spectrum, thereby enabling detection of the test substance with high sensitivity.

[0008] The present invention relates to a reagent used in the preparation of a measurement sample by the above-mentioned preparation method, which comprises a linker that is not bound to metal nanoparticles.

[0009] The present invention relates to a reagent kit used for preparing a measurement sample by the above-mentioned preparation method, which contains the above-mentioned reagent and metal nanoparticles packaged separately from the linker. Effect of the Invention

[0010] According to the present invention, the detection sensitivity of an analyte can be improved. [Brief description of the drawings]

[0011] [Figure 1] FIG. 1 is a diagram showing a method for preparing a measurement sample. [Diagram 2] FIG. 2 is a diagram illustrating an example of the configuration of an analysis device. [Diagram 3](A) is a SERS spectrum of a measurement sample (Phe) prepared according to the Example. (B) is a SERS spectrum of a measurement sample prepared according to the Example without adding a test substance. (C) is a SERS spectrum of a measurement sample prepared according to the Example without adding DSP. (D) is a SERS spectrum of a negative control sample to which neither a test substance nor DSP was added. [Figure 4] The SERS spectra are shown for each of the 20 amino acids used as test substances. Symbol a in the figure indicates the spectrum when the test substance was added, and symbol b indicates the spectrum of the negative control where no test substance was added. [Diagram 5] The SERS spectrum when a dipeptide was used as a test substance is shown. The symbol c in the figure indicates the spectrum of a negative control in which no test substance was added. [Figure 6] (A) shows the SERS spectrum when Aβ42 was added as a test substance and the spectrum of a negative control where no test substance was added. (B) shows the SERS spectrum when Aβ40 was added as a test substance and the spectrum of a negative control where no test substance was added. (C) shows the SERS spectrum when Aβ38 was added as a test substance and the spectrum of a negative control where no test substance was added. (D), (E), and (F) show bright-field images of the gold nanoparticle aggregates in the measurement sample used to acquire the spectra in (A), (B), and (C), respectively. (G) shows a bright-field image of the gold nanoparticle aggregates in the negative control measurement sample. [Figure 7] 1 shows SERS spectra of a measurement sample prepared by the sample preparation method of an example and a measurement sample prepared by the sample preparation method of a comparative example using phenylalanine, tryptophan, or tyrosine as a test substance. [Figure 8] 1 shows SERS spectra of a measurement sample prepared by the sample preparation method of the Example and a measurement sample prepared by the sample preparation method of the Comparative Example using a dipeptide as a test substance. [Figure 9]Measurement samples were prepared by mixing only gold nanoparticles and only gold nanoparticles and DSP, and the absorption spectra of the samples were obtained. In the figure, symbol a indicates the spectrum of the measurement sample containing only gold nanoparticles, and symbol b indicates the spectrum of the measurement sample containing only gold nanoparticles and DSP. [Figure 10] The following shows SERS spectra obtained by preparing measurement samples using linkers of different chain lengths. [Figure 11] Measurement samples were prepared using metal nanoparticles with different particle sizes and shapes, and the SERS spectra obtained are shown. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0012] 1. Preparation of measurement samples This preparation method prepares a measurement sample containing an aggregate of metal nanoparticles bound to a test substance. As shown in FIG. 1, this preparation method includes (i) contacting the test substance with the linker to bind them, and (ii) contacting the linker bound to the test substance with the metal nanoparticles to bind them. Depending on the test substance, the method may further include (iii) adding an inorganic salt or an acid after contacting the linker bound to the test substance with the metal nanoparticles.

[0013] In this preparation method, the analyte is reacted with the linker first, and then the complex of the analyte and the linker is reacted with the metal nanoparticles, thereby improving the detection sensitivity of the analyte.

[0014] The measurement sample is preferably a sample to be subjected to spectroscopic analysis of the test substance. Spectroscopic analysis may be performed by fluorescence spectroscopy, surface plasmon resonance (SPR), infrared spectroscopy, etc., preferably Raman scattering analysis, more preferably Surface Enhanced Raman Scattering (SERS) analysis.

[0015] (i) Contact of the test substance with the linker The test substance may include at least one selected from the group consisting of nucleic acids such as RNA and DNA, amino acids, polypeptides, catecholamines, polyamines, organic acids, extracellular vesicles, and viruses. Here, a "polypeptide" is a compound in which two or more amino acids are linked by peptide bonds. Examples include dipeptides, oligopeptides, and proteins. The test substance has at least one functional group selected from an amino group, a carboxyl group, and a hydroxyl group, and is bonded to a linker, which will be described later, by utilizing this functional group. The test substance is contained in a solvent such as water or a buffer solution, or is contained in a liquid biological sample such as blood, serum, plasma, saliva, ascites, pleural effusion, cerebrospinal fluid, interstitial fluid, or urine. The linker is not limited as long as it has a reactive group that reacts with the functional group and bonds to the metal nanoparticles described below. The linker is represented, for example, by the following general formula (I).

[0016] R 3 -O-CO-R 1 -SSR 2 -CO-OR 4 (I) (In the above formula, R 1 and R 2 represents the same or different alkylene groups having 1 to 12 carbon atoms. R 3 and R 4 represent the same or different reactive groups. Preferably, R 1 and R 2 The alkylene group constituting R has 2 to 10 carbon atoms. 1 and R 2 It is more preferable that are the same.

[0017] R 3 and R 4 R is a reactive group that bonds with the functional group of the analyte. 3 and R 4are preferably the same. When the functional group of the test substance is an amino group, examples of the reactive group include N-hydroxysuccinimide ester, isothiocyanate, isocyanate, acyl azide, sulfonyl chloride, aldehyde, imide ester, fluorobenzene, epoxide, carbodiimide, carbonate, fluorophenyl ester, etc. Preferably, the reactive group is N-hydroxysuccinimide ester.

[0018] When the reactive group is an N-hydroxysuccinimide ester, the linker is preferably at least one selected from the group consisting of dithiobis(succinimidyl propionate), dithiobis(succinimidyl undecanoate), dithiobis(succinimidyl octanoate), and dithiobis(succinimidyl hexanoate).

[0019] When the functional group of the test substance is a carboxyl group, examples of the reactive group include a hydroxyl group and an amino group. When the functional group of the test substance is a hydroxyl group, examples of the reactive group include N-hydroxysuccinimide ester, isothiocyanate, isocyanate, acyl azide, sulfonyl chloride, aldehyde, imido ester, fluorobenzene, epoxide, carbodiimide, carbonate, and fluorophenyl ester. The linker may be of one type only, or of two or more types in combination.

[0020] The sample containing the test substance preferably contains the test substance at about 1 nM to 1 mM, for example. However, the content of the test substance in the sample containing the test substance may be unknown, so this does not apply in such cases. The pH of the sample containing the test substance is preferably about 6 to 8, for example. Therefore, if the test substance is not a liquid sample, it is preferably dissolved in a buffer solution such as PBS having a pH of about 6 to 8. The linker is preferably dissolved in an organic solvent such as dimethylsulfamide or dimethylsulfoxide to a concentration of about 1 nM to 1 mM.

[0021] Approximately 1 μL to 1 mL of a sample containing the test substance is mixed with approximately 1 μL to 1 mL of linker solution, and the mixture is allowed to stand or stir at approximately 18°C ​​to 28°C for approximately 0.5 to 5 hours, preferably 1 to 3 hours, to allow the test substance to come into contact with the linker and bind.

[0022] Here, the pH of the reaction solution in which the test substance and the linker are brought into contact is preferably about 6 to 8. This pH is close to the conditions in vivo, so a liquid sample from a living body can be used as is to prepare a measurement sample.

[0023] (ii) Contact of the linker bound to the test substance with the metal nanoparticles As the metal nanoparticles, nanoparticles made of at least one metal selected from the group consisting of gold, silver, platinum, copper and palladium can be used. The particle diameter of the metal nanoparticles can be 10 nm to 150 nm. It is preferably 40 nm to 80 nm, more preferably 40 nm or 80 nm. The shape of the metal nanoparticles is not limited. Metal nanoparticles such as spherical, rod-shaped, shell-shaped, cube-shaped, triangular plate-shaped, star-shaped or wire-shaped can be used. Spherical metal nanoparticles are preferred. Metal nanoparticles are available from, for example, BBI Solutions, and can be used. The method for measuring the particle diameter and particle shape follows the information provided by the manufacturer. The particle diameter is a volume-based median diameter measured by a particle size distribution measuring device using a laser diffraction / scattering method. Examples of such particle size distribution measuring devices include the "Microtrac MT3000II" manufactured by Nikkiso Co., Ltd. In this specification, "particle diameter" means diameter. There are no limitations on the contact between the linker bound to the test substance and the metal nanoparticles, so long as it is carried out under conditions that allow the linker to bind to the surface of the metal nanoparticles.

[0024] For example, in the above (i), about 1 μL to 1 mL of the reaction solution prepared by contacting the test substance with the linker is diluted with the same amount of water (preferably ultrapure water), and a metal nanoparticle solution (9.0 × 10 5 ~9.0×1015 Add about 10 μL to 1 mL of a mixture of about 100 μL particles / mL. This mixture is allowed to stand or stir at about 18°C ​​to 28°C for about 5 to 120 minutes, preferably 10 to 60 minutes, to bring the linker bound to the test substance into contact with the metal nanoparticles. This allows the formation of aggregates of the linker bound to the test substance and the metal nanoparticles. Mixing of the linker bound to the test substance and the metal nanoparticles is preferably performed on a glass bottom plate.

[0025] An inorganic salt or an acid may be added to the reaction system as a substance that promotes the formation of aggregates. An example of the inorganic salt is sodium chloride. An example of the acid is trifluoroacetic acid. The concentration of the inorganic salt is not particularly limited as long as it promotes the formation of aggregates, but may be, for example, 10 mM to 100 mM in final concentration. The concentration of the acid is not particularly limited as long as it promotes the formation of aggregates, but may be, for example, 10 mM to 100 mM in final concentration. After mixing the inorganic salt or acid, the mixture is allowed to stand or stirred at 4°C to 30°C for about 1 hour to 24 hours to form aggregates of metal nanoparticles.

[0026] 2.Analysis method An analytical apparatus for analyzing the measurement sample prepared by the preparation method in 1 above, and an analytical method executed by the analytical apparatus will be described below.

[0027] An overview of the configuration of the analytical device 1 is shown in Fig. 2. The analytical device 1 includes a microscope 10 for observing aggregates, a laser light source 20 that supplies excitation light with which the microscope 10 irradiates a measurement sample, a control unit 30 that controls the microscope 10 and the laser light source 20, and an output unit 40 connected to the control unit 30. Examples of devices that include the microscope 10 and the laser light source 20 include a slit-scanning confocal Raman microscope and a multifocus Raman microscope. The control unit 30 can be a general-purpose computer.

[0028] The control unit 30 controls the laser light source 20 to irradiate the excitation light, and acquires an image from the microscope 10.

[0029] When the microscope 10 is a slit-scanning confocal Raman microscope, the control unit 30 performs the analysis under the following conditions, for example. Excitation wavelength: 660 nm Excitation intensity: 2.5 mW / μm 2 Exposure time: 0.5sec / line Objective lens: ×40 NA1.25 The above conditions can be appropriately set depending on the type of test substance, the material of the metal nanoparticles, and the shape of the metal nanoparticles.

[0030] Under the above conditions, the laser irradiation is line irradiation, but spot irradiation may also be used. The control unit 30 acquires a spectrum from the measurement sample, and outputs information about the test substance to the output unit 40 based on the acquired spectrum.

[0031] The information on the test substance is intended to be information on the type of the test substance. By recording characteristic spectroscopic information on various substances in a database in advance, and comparing the spectral information with the spectrum of the test substance, information on the test substance can be obtained from similar spectra.

[0032] Here, the spectrum used may be one obtained from one location on the measurement sample, or may be spectra obtained from multiple locations on the measurement sample.

[0033] 3. Reagents and reagent kits for preparing measurement samples The reagent for preparing the measurement sample described in 1 above contains a linker that is not bound to the metal nanoparticles.

[0034] The reagent kit for preparing the measurement sample described in 1 above includes a linker that is not bound to metal nanoparticles, and metal nanoparticles packaged separately from the linker. EXAMPLES

[0035] Examples are shown below, but the present invention is not limited to these examples.

[0036] 1. Example (1) Material The test substances used were 20 kinds of amino acids, 39 kinds of dipeptides, and 3 kinds of amyloid β (Aβ). The linker used was DSP (Dithiobis (Succinimidyl Propionate)) (Dojindo Laboratories, product code D629). The metal nanoparticles used were gold nanoparticles φ40 nm (9.0 × 10 10 particles / Ml aqueous solution; BBI, catalog number: EMGC40) was used.

[0037] (2) Sample preparation A scheme of the sample preparation method of the embodiment is shown in FIG. i. 1 μL of a test substance solution (1 mM) (solvent: PBS) was reacted with 1 μL of a 200 μM DSP solution (solvent: dimethylformamide) at room temperature for 2 to 3 hours. ii. 2 μL of the mixture from i above, 27 μL of water, and 30 μL of the gold nanoparticle aqueous solution were dropped onto a glass bottom dish and reacted at room temperature for 2 to 3 hours. iii. 1 μL of a 9% aqueous trifluoroacetic acid solution was dropped and reacted overnight at 4° C. to generate aggregates, which were used as SERS measurement samples.

[0038] 2. Comparative Example (Prior Art) (1) Material The same materials as in the example were used.

[0039] (2) Sample preparation i. 1 μL of 200 μM DSP solution (solvent: dimethylformamide) was reacted with the gold nanoparticle aqueous solution at room temperature for 2 to 3 hours. ii. 31 mL of the mixture from i. above, 1 μL of the test substance solution (1 mM) (solvent: PBS), and 27 μL of water were dropped onto a glass bottom dish and reacted at room temperature for 2 to 3 hours. The N-terminus of the test substance was bound to the surface-modified gold nanoparticles by this reaction. iii. 1 μL of a 9% aqueous trifluoroacetic acid solution was dropped and reacted overnight at 4° C. to generate aggregates, which were used as SERS measurement samples.

[0040] 3. Acquiring SERS Spectra A slit-scanning confocal Raman microscope was used to obtain the SERS spectrum. Laser irradiation was performed using the line irradiation method. The measurement conditions were as follows: Excitation wavelength: 660 nm Excitation intensity: 2.5 mW / μm 2 Exposure time: 0.5sec / line Objective lens: ×40 NA1.25

[0041] 4.Results (1) Acquisition of a substance-specific spectrum according to the embodiment In order to verify whether the embodiment can obtain a spectral peak specific to the test substance, phenylalanine (Phe) was used as the test substance to verify the difference in the spectrum with and without the linker. Phe was added so that the final concentration of the sample was 30 μM. The results are shown in FIG. 3. FIG. 3(A) is a SERS spectrum of a measurement sample prepared according to the embodiment. FIG. 3(B) is a SERS spectrum of a measurement sample prepared according to the embodiment without adding the test substance. FIG. 3(C) is a SERS spectrum of a measurement sample prepared according to the embodiment without adding DSP. FIG. 3(D) is a SERS spectrum of a negative control sample to which neither the test substance nor DSP was added.

[0042] Each spectrum represents an average of SERS spectra acquired at 10 locations. As a result, it was possible to obtain a spectral peak dependent on the test substance only in the measurement sample prepared according to the embodiment (the peak is indicated by the arrow in FIG. 3(A)).

[0043] Next, we used each of the 20 types of amino acids as a test substance to verify whether it was possible to obtain a SERS spectrum peak specific to the test substance. The results are shown in Figure 4. Symbol a in the figure indicates the average spectrum when the test substance was added, and symbol b indicates the average spectrum of the negative control where no test substance was added. For each amino acid, we were able to obtain a spectrum peak dependent on the test substance (the peaks are indicated by the arrowheads in Figure 4).

[0044] Next, it was verified whether a spectral peak specific to the test substance could be obtained using dipeptides. The dipeptides used are shown in Figure 5. For dipeptides consisting of different amino acids, such as Phe-Ala and Ala-Phe, the positions of the two amino acids were rearranged, and an average spectrum was obtained for each. An average spectrum was also obtained for a negative control in which no dipeptide was added. The symbol c in the figure indicates the negative control. A specific spectral peak could be detected for each dipeptide used in the experiment (the peak is indicated by the arrowhead in Figure 5). Furthermore, for dipeptides consisting of different amino acids, similar spectral peaks could be obtained even when the positions of the two amino acids were rearranged.

[0045] Next, it was verified whether a peak of a test substance-specific SERS spectrum could be obtained using Aβ42, Aβ40, or Aβ38. The results are shown in FIG. 6. FIG. 6(A) shows the average spectrum when Aβ42 was added as a test substance and the average spectrum of a negative control to which no test substance was added. FIG. 6(B) shows the average spectrum when Aβ40 was added as a test substance and the average spectrum of a negative control to which no test substance was added. FIG. 6(C) shows the average spectrum when Aβ38 was added as a test substance and the average spectrum of a negative control to which no test substance was added. FIG. 6(D), FIG. 6(E), and FIG. 6(F) show bright-field images of aggregates of gold nanoparticles in the measurement sample used to obtain the average spectra of FIG. 6(A), FIG. 6(B), and FIG. 6(C), respectively. FIG. 6(G) shows a bright-field image of aggregates of gold nanoparticles in the measurement sample of the negative control. Specific spectral peaks were observed for all of Aβ42, Aβ40, and Aβ38 (peaks are indicated by the arrowheads in Figures 6(A), 6(B), and 6(C)).

[0046] (2) Verification of the effects of the embodiment The effects of the embodiment were verified using a measurement sample prepared by the sample preparation method of the embodiment and a measurement sample prepared by the sample preparation method of the comparative example.

[0047] Phenylalanine, tryptophan, or tyrosine was used as the test substance, and an average spectrum was obtained. In addition, an average spectrum was similarly obtained for the negative control. The results are shown in FIG. 7. For the measurement samples prepared by the preparation method of the Example, a spectral peak specific to the test substance was confirmed regardless of whether phenylalanine, tryptophan, or tyrosine was used as the test substance (the peak is indicated by the arrowhead in FIG. 7). On the other hand, for the measurement samples prepared by the preparation method of the Comparative Example, a spectral peak specific to any amino acid was not confirmed. This shows that the sample preparation method of the Example can improve detection sensitivity compared to the Comparative Example, which is a conventional method.

[0048] Next, the effect of the embodiment was verified using a measurement sample prepared by the sample preparation method of the embodiment and a measurement sample prepared by the sample preparation method of the comparative example using dipeptide (Phe-Trp, Gly-Phe), Phe-(Tyr)8, or Aβ38 as the test substance. Phe-(Tyr)8 is intended to mean a peptide in which eight tyrosine residues are bound after phenylalanine. In addition, an average spectrum was similarly obtained for the negative control. The results are shown in FIG. 8. For the measurement sample prepared by the preparation method of the embodiment, a spectral peak specific to the test substance was confirmed when any of the dipeptide, Phe-(Tyr)8, and Aβ38 was used (the peak is indicated by the arrowhead in FIG. 8). On the other hand, for the measurement sample prepared by the preparation method of the comparative example, no specific spectral peak was confirmed for any amino acid. This shows that the preparation method of the measurement sample of the embodiment can increase the detection sensitivity more than the comparative example, which is a conventional method, whether it is a low molecular weight substance or a high molecular weight substance such as Aβ.

[0049] (3) Examination of the mechanism of enhanced detection sensitivity Next, in the examples, the reason for the enhanced detection sensitivity was examined. Measurement samples were prepared by mixing only gold nanoparticles and only gold nanoparticles and DSP, and the absorption spectra of the measurement samples were obtained. The results are shown in FIG. 9. In the figure, the symbol a indicates the spectrum of the measurement sample of only gold nanoparticles, and the symbol b indicates the spectrum of the measurement sample of only gold nanoparticles and DSP. The measurement sample of only gold nanoparticles shows one absorption spectrum peak near 540 nm, but the measurement sample of only gold nanoparticles and DSP shows absorption from 600 nm to 700 nm. This absorption was thought to be due to the aggregation of gold nanoparticles caused by the addition of DSP. In the conventional method, the metal nanoparticles and the linker are mixed first, so it was thought that the metal nanoparticles aggregate before the binding of the test substance to the linker occurs, and the test substance does not sufficiently enter the aggregate.

[0050] (4) Effect of linker chain length To verify the effect of the linker chain length on detection sensitivity, measurement samples were prepared using DSP, DSH (Dithiobis (Succinimidyl Hexanoate)), and DSU (Dithiobis (Succinimidyl Undecanoate)), and the average SERS spectrum was obtained. The results are shown in Figure 10. When any linker was used, a spectral peak specific to the test substance was confirmed. This result shows that the preparation method of the present example can be used regardless of the type of linker.

[0051] (5) Effects of particle size and shape of metal nanoparticles The effect of the particle size and shape of metal nanoparticles on the detection sensitivity was examined. Spherical gold nanoparticles with particle sizes of φ40 nm, φ50 nm, φ60 nm, φ80 nm, φ100 nm, and φ150 nm; and sea urchin-shaped gold nanoparticles with φ50 nm and φ90 nm were used to obtain average SERS spectra using phenylalanine as the test substance. The results are shown in Figure 11. Spectral peaks specific to phenylalanine were detected for all particle sizes and shapes. The detection sensitivity was particularly high for spherical particles with a diameter of φ40 nm and spherical particles with a diameter of φ80 nm.

Claims

1. A method for preparing a measurement sample containing an aggregate of metal nanoparticles bound to a test substance, comprising the steps of: contacting the test substance with a linker to bind the test substance; contacting the linker bound to the test substance with the metal nanoparticles to bind them; The preparation method comprising:

2. The preparation method according to claim 1 , wherein the test substance has a functional group and the linker has a reactive group that reacts with the functional group.

3. The preparation method according to claim 2, wherein the functional group is at least one selected from the group consisting of an amino group, a carboxyl group, and a hydroxyl group.

4. The preparation method according to claim 3, wherein the functional group is an amino group and the reactive group is at least one selected from the group consisting of N-hydroxysuccinimide ester, isothiocyanate, isocyanate, acyl azide, sulfonyl chloride, aldehyde, imido ester, fluorobenzene, epoxide, carbodiimide, carbonate, and fluorophenyl ester.

5. 5. The method of claim 4, wherein the reactive group is an N-hydroxysuccinimide ester and the linker is at least one selected from the group consisting of dithiobis(succinimidyl propionate), dithiobis(succinimidyl undecanoate), dithiobis(succinimidyl octanoate), and dithiobis(succinimidyl hexanoate).

6. The preparation method according to any one of claims 1 to 5, wherein the metal nanoparticles are nanoparticles made of at least one metal selected from the group consisting of gold, silver, platinum, copper and palladium.

7. The method according to any one of claims 1 to 6, wherein the particle size of the metal nanoparticles is from 10 nm to 150 nm.

8. The preparation method according to claim 1 , further comprising adding an inorganic salt or an acid after contacting the linker bound to the test substance with the metal nanoparticles.

9. The preparation method according to any one of claims 1 to 8, wherein the test substance is at least one substance selected from the group consisting of amino acids, polypeptides, nucleic acids, catecholamines, polyamines, organic acids, extracellular vesicles, and viruses.

10. The preparation method according to any one of claims 1 to 9, wherein the sample containing the test substance is blood, serum, plasma, saliva, or a body fluid, or is a solution of the test substance in water or a buffer solution.

11. The method according to claim 1 , wherein the measurement sample is used for surface-enhanced Raman scattering analysis.

12. Obtaining a spectrum from a sample prepared by the preparation method according to any one of claims 1 to 11; outputting information about the test substance based on the acquired spectroscopic spectrum; , an analytical method.

13. A reagent for use in the preparation method according to any one of claims 1 to 12, comprising a linker that is not bound to the metal nanoparticles.

14. A reagent kit for use in the preparation method according to any one of claims 1 to 11, comprising the preparation reagent according to claim 13 and metal nanoparticles packaged separately from the linker.

Citation Information

Patent Citations

  • Metal-coated nanocrystalline silicon as a substrate for active surface-enhanced Raman spectroscopy (sers)

    JP2006514286A

  • Complex of protein and fine particle, and method for producing the same

    JP2011079758A

  • Raman-active reagents and the use thereof

    US20050089901A1

  • Modification of metal nanoparticles for improved analyte detection by surface enhanced Raman spectroscopy (SERS)

    US20070155021A1

Cited By

  • Method for analyzing test target material, analyzer, method for training, analysis system, and analysis program

    JP2022135652A